메뉴 건너뛰기




Volumn 67, Issue , 2015, Pages S43-S46

The 'MAP strategy' (Maximum aspiration of atherothrombus and adjunctive glycoprotein IIb/IIIa inhibitor utilization combined with prolonged inflation of balloon/stent) for preventing no-reflow in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A retrospective analysis of seventy-one cases

Author keywords

No reflow phenomenon; Percutaneous coronary intervention; Thrombectomy

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; TIROFIBAN; FIBRINOGEN RECEPTOR;

EID: 84961124524     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ihj.2015.11.014     Document Type: Article
Times cited : (8)

References (9)
  • 1
    • 0023258694 scopus 로고
    • Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge
    • J. Chesebro, G. Knatterud, R. Roberts, and et al. Thrombolysis In Myocardial Infarction (TIMI) Trial. Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circ Am Heart Assoc 76 1987 142 154
    • (1987) Circ Am Heart Assoc , vol.76 , pp. 142-154
    • Chesebro, J.1    Knatterud, G.2    Roberts, R.3
  • 2
    • 0032537574 scopus 로고    scopus 로고
    • Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade
    • A. Van't Hof, A. Liem, H. Suryapranata, and et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302
    • (1998) Circulation , vol.97 , pp. 2302
    • Van'T Hof, A.1    Liem, A.2    Suryapranata, H.3
  • 3
    • 44649157131 scopus 로고    scopus 로고
    • Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction study (TAPAS): A 1-year follow-up study
    • P.J. Vlaar, T. Svilaas, I.C. van der Horst, and et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction study (TAPAS): a 1-year follow-up study Lancet 371 2008 1915 1920
    • (2008) Lancet , vol.371 , pp. 1915-1920
    • Vlaar, P.J.1    Svilaas, T.2    Van Der Horst, I.C.3
  • 4
    • 58249084644 scopus 로고    scopus 로고
    • Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: The EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial
    • G. Sardella, M. Mancone, C. Bucciarelli-Ducci, and et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial J Am Coll Cardiol 53 2009 309 315
    • (2009) J Am Coll Cardiol , vol.53 , pp. 309-315
    • Sardella, G.1    Mancone, M.2    Bucciarelli-Ducci, C.3
  • 5
    • 34548359246 scopus 로고    scopus 로고
    • Abciximab in primary coronary stenting of ST-elevation myocardial infarction: A European meta-analysis on individual patients' data with long-term follow-up
    • G. Montalescot, D. Antoniucci, A. Kastrati, and et al. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up Eur Heart J 28 2007 443 449
    • (2007) Eur Heart J , vol.28 , pp. 443-449
    • Montalescot, G.1    Antoniucci, D.2    Kastrati, A.3
  • 6
    • 10644269830 scopus 로고    scopus 로고
    • Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: A meta-analysis of randomized, controlled trials
    • J.O. De Queiroz Fernandes Araújo, H.H. Veloso, J.M. Braga De Paiva, and et al. Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomized, controlled trials Am Heart J 148 2004 937 943
    • (2004) Am Heart J , vol.148 , pp. 937-943
    • De Queiroz Fernandes Araújo, J.O.1    Veloso, H.H.2    Braga De Paiva, J.M.3
  • 7
    • 2342428087 scopus 로고    scopus 로고
    • Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials
    • D.E. Kandzari, V. Hasselblad, J.E. Tcheng, and et al. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials Am Heart J 147 2004 457 462
    • (2004) Am Heart J , vol.147 , pp. 457-462
    • Kandzari, D.E.1    Hasselblad, V.2    Tcheng, J.E.3
  • 8
    • 81855185377 scopus 로고    scopus 로고
    • Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of observational studies
    • R. Kouz, S. Kouz, E. Schampaert, and et al. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies Int J Cardiol 153 2011 249 255
    • (2011) Int J Cardiol , vol.153 , pp. 249-255
    • Kouz, R.1    Kouz, S.2    Schampaert, E.3
  • 9
    • 70450141566 scopus 로고    scopus 로고
    • A comparison of abciximab and small molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: A meta-analysis of contemporary randomized controlled trials
    • H. Gurm, U. Tamhane, P. Meier, and et al. A comparison of abciximab and small molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials Circ Cardiovasc Interv 2009 108
    • (2009) Circ Cardiovasc Interv , pp. 108
    • Gurm, H.1    Tamhane, U.2    Meier, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.